Drug shortage: Clindamycin Phosphate Injection (CLINDAMYCIN PHOSPHATE, CLEOCIN PHOSPHATE, CLINDAMYCIN IN 5 PERCENT DEXTROSE)
FDA lists 23 presentations as Current. Availability: Unavailable (4), Limited Availability (3), Available (10). Reason: Other; Discontinuation of the manufacture of the drug. Companies: Baxter Healthcare, Pfizer Inc., Sagent Pharmaceuticals, Sandoz Inc..
- Published by source
- 2023-03-21
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-27
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Clindamycin Phosphate Injection CLINDAMYCIN PHOSPHATE CLEOCIN PHOSPHATE CLINDAMYCIN IN 5 PERCENT DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: December 2026
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-03-21
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #899 | new | 2026-10-22 | 61657936fdd9…f44c93 | 5fe09c8bb2c4…994d09 |
| #1135 | update | 2026-10-23 | dd42070c2f86…ceeb23 | 446d2b233308…06fd4e |
| #1415 | update | 2026-10-23 | a96c5a8e5020…541777 | bf9c6349669c…f7e722 |
| #2217 | update | 2026-10-27 | e961b520b916…d635d4 | 4517d23acf44…ae5ae4 |
| #2398 | update | 2026-10-27 | 2fc2f9bcb946…cb462e | a1f011054eaf…b5e983 |
Chain head: #2504 757b4a5960ed…72a932